ICIs	Immune checkpoint inhibitors
OS	Overall survival
PFS	Progression-free survival
HR	Hazard ratio
OR	Odds ratio
NSCLC	Non-small cell lung cancer
PD-1	Programmed cell death protein 1
PD-L1	Programmed death-ligand 1
CTLA-4	Cytotoxic T-lymphocyte–associated antigen 4
TME	Tumor microenvironment
CIADM	Checkpoint inhibitor-associated autoimmune diabetes mellitus
irAEs	Immune-related adverse events
HOMA-IR	Homeostatic Model Assessment for Insulin Resistance
HbA1c	Hemoglobin A1c
FSH	follicle stimulating hormone
LH	luteinizing hormone
CRH	corticotropin-releasing hormone